RVL Pharmaceuticals PLC (RVLPQ)
0.00
USD |
OTCM |
May 31, 16:00
RVL Pharmaceuticals Revenue (Quarterly): 8.258M for June 30, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 8.258M |
| March 31, 2023 | 8.832M |
| December 31, 2022 | 9.807M |
| September 30, 2022 | 10.02M |
| June 30, 2022 | 8.448M |
| March 31, 2022 | 21.44M |
| December 31, 2021 | 2.86M |
| September 30, 2021 | 2.196M |
| June 30, 2021 | 11.51M |
| March 31, 2021 | 0.935M |
| December 31, 2020 | 1.135M |
| September 30, 2020 | 25.75M |
| Date | Value |
|---|---|
| June 30, 2020 | 0.234M |
| March 31, 2020 | 48.65M |
| December 31, 2019 | 59.91M |
| September 30, 2019 | 65.46M |
| June 30, 2019 | 57.53M |
| March 31, 2019 | 57.13M |
| December 31, 2018 | 65.70M |
| September 30, 2018 | 66.34M |
| June 30, 2018 | 71.86M |
| March 31, 2018 | 59.80M |
| December 31, 2017 | 76.33M |
| September 30, 2017 | 53.74M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.234M
Minimum
Jun 2020
65.46M
Maximum
Sep 2019
20.18M
Average
9.807M
Median
Dec 2022
Revenue (Quarterly) Benchmarks
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -23.89M |
| Total Expenses (Quarterly) | 16.38M |
| EPS Diluted (Quarterly) | -0.24 |
| Gross Profit Margin (Quarterly) | 76.44% |
| Profit Margin (Quarterly) | -289.3% |